Modification of low density lipoprotein potentiates its inhibitory effect on catecholamine secretion in cultured bovine adrenal medullary cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 360, Issue 1, 1999, Pages 99-102

  Kajiwara, Koji ^a   Yanagihara, Nobuyuki ^a   Ioka, Tatsuya ^a   Tsutsui, Masato ^a   Yashiro, Akira ^a   Toyohira, Yumiko ^a   Nakashima, Yasuhide ^a   Izumi, Futoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Acetylation; Adrenal medullary cells; Atherosclerosis; Catecholamine secretion; Low density lipoprotein; Oxidation

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CARBACHOL; CATECHOLAMINE; COPPER SULFATE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACETYLATION; ADRENAL CELL; ADRENAL MEDULLA; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CATECHOLAMINE RELEASE; CATTLE; CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; LIPID OXIDATION; NONHUMAN; RISK FACTOR;

ADRENAL MEDULLA; ANIMALS; CATECHOLAMINES; CATTLE; CELLS, CULTURED; LIPOPROTEINS, LDL; RECEPTORS, NICOTINIC;

EID: 0032819432     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900039     Document Type: Article

References (26)

1. Bochkov VN, Voino-Yasenetskaya TA, Tkachuk VA (1991) Epinephrine potentiates activation of human platelets by low density lipoproteins. Biochim Biophys Acta 1097:123-127
2. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310
3. Cardona-Sanclemente LE, Born GVR (1992) Adrenaline increases the uptake of low-density lipoproteins in carotid arteries of rabbits. Atherosclerosis 96:215-218
4. Cox DA, Cohen ML (1996a) Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol Rev 48:3-19
5. Cox DA, Cohen ML (1996b) Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein. J Pharmacol Exp Ther 276: 1095-1103
6. Cruickshank JM (1990) The role of beta-blockers in preventing heart attacks and catecholamine-induced cardiovascular damage. Cardiovasc Rev Rep 11:10-13
7. Daugherty A, Zweifel BS, Sobel BE, Schonfeld G (1988) Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis 8:768-777
8. De Vries HE, Ronken E, Reinders J-H, Buchner B, Van Berkel TJC, Kuiper J (1998) Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. FASEB J 12:111-118
9. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337
10. Habeeb AF (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328-336
11. Hatch FT, Lees RS (1968) Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6:1-63
12. Henriksen T, Mahoney EM, Steinberg D (1981) Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78:6499-6503
13. Henriksen T, Mahoney EM, Steinberg D (1983) Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 3:149-159
14. Izumi F, Toyohira Y, Kobayashi H, Yanagihara N (1990) Lysophosphatidylcholine inhibiton of ion channels and catecholamine secretion in bovine adrenal medulla (abstr). Soc Neurosci Abstr 16:527
15. Kajiwara K, Yanagihara N, Tsutsui M, Yashiro A, Tasaki H, Nakashima Y, Izumi F (1998) Atherogenic lipoproteins inhibit catecholamine secretion in cultured bovine adrenal medullary cells. Naunyn-Schmiedeberg's Arch Pharmacol 358:308-314
16. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-162
17. Kukreja RS, Datta BN, Chakravarti RN (1981) Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 40:291-298
18. Lamb DJ, Mitchinson MJ, Leake DS (1995) Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett 374:12-16
19. Morel DW, Hessler JR, Chisolm GM (1983) Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24:1070-1076
20. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82:3000-3004
21. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887
22. Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963-20966
23. Weil-Malherbe H, Bone AD (1952) The chemical estimation of adrenaline-like substances in blood. Biochem J 51:311-318
24. Yanagihara N, Isosaki M, Ohuchi T, Oka M (1979) Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells. FEBS Lett 105:296-298
25. 2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells. Mol Pharmocol 46:423-430
26. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095